1,1'-Carbonyldiimidazole → 7-bromo-4,4-dimethyl-1H-benzo[d][1,3]oxazin-2(4H)-one

HRID 2209289Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 2209289
[NH2:1][C:2]1[CH:7]=[C:6]([Br:8])[CH:5]=[CH:4][C:3]=1[C:9]([OH:12])([CH3:11])[CH3:10].C1N=CN([C:18](N2C=NC=C2)=[O:19])C=1>C1COCC1>[Br:8][C:6]1[CH:5]=[CH:4][C:3]2[C:9]([CH3:10])([CH3:11])[O:12][C:18](=[O:19])[NH:1][C:2]=2[CH:7]=1

Komponenten

4

Reaktionsbedingungen

Temperatur
60 °C

Versuchsvorschrift

Into the solution of 2-(2-amino-4-bromophenyl)propan-2-ol (2.3 g) in THF (50 mL) was added CDI (1.95 g) at rt., then the mixture was warmed to 60° C. and stirred for overnight. After solvent removal, the residue was dissolved in ethyl acetate and washed with 1M of HCl(aq) and brine, and dried with dry agent. After removal of the solvent, the residue was crystallized from DCM and hexane to provide 2.3 g of 7-bromo-4,4-dimethyl-1H-benzo[d][1,3]oxazin-2(4H)-one 7.37 was synthesized. LCMS [M+H]+: 252.71. 1H NMR (400 MHz, Chloroform-d) δ 9.30 (s, 1H), 7.18 (d, d, J=8.2, 1.8 Hz, 1H), 7.06 (d, J=1.8 Hz, 1H), 6.99 (d, J=8.2 Hz, 1H), 1.71 (s, 6H).

Aufarbeitung

  1. customAfter solvent removal
  2. dissolutionthe residue was dissolved in ethyl acetate
  3. washwashed with 1M of HCl(aq) and brine
  4. customdried
  5. customwith dry agent
  6. customAfter removal of the solvent
  7. customthe residue was crystallized from DCM and hexane

Quellen und Nachweise

ORD-Eintrag
ord-1b5f412ef6184224aafa7c9ad43213fe
Quelldatensatz
uspto-grants-2016_06
Patentnummer
US09376441B2

Notizen zur Reaktion

Wird geladen…